卒中后面瘫核心结局指标集(COS)开发:专业共识研究方案
本方案描述了卒中后面瘫核心结局指标集(COS)开发中专业利益相关者环节的详细流程,旨在通过系统评价、质性访谈、德尔菲调查和共识会议,在临床医生与研究者之间就「测什么」达成共识,以标准化结局测量、促进证据合成。
要点
- 面瘫影响45-60%的急性卒中患者,结局测量异质性阻碍证据合成。
- 本环节聚焦临床医生与研究者,通过多轮德尔菲调查和共识会议确定关键结局。
- 遵循COS-STAD和COS-STAP标准,计划招募最多200名国际参与者。
核心结论
- 该方案将建立临床医生与研究者对卒中后面瘫关键结局指标的共识,标准化测量以促进证据合成和减少研究浪费。
研究设计与样本
- 本研究遵循COS-STAD和COS-STAP推荐,为多阶段COS开发项目中专业利益相关者环节的方案。
- 开发过程包括五个步骤:结局生成、招募最多200名国际临床医生和研究者(每组至少30人)、多轮德尔菲调查、在线共识会议(每组至少5人)和结果传播。
- 结局生成基于系统评价、与有亲身经历的共同研究者咨询以及对卒中参与者的质性访谈发现。
关键数值与推荐
- 面瘫影响45-60%的急性卒中患者。
- 计划招募最多200名国际临床医生和研究者,每组至少30人。
- 在线共识会议每组至少5人参加。
临床怎么用
- 标准化结局测量将促进研究结果的更有效合成,减少研究浪费,加速干预开发。
- 有亲身经历者从开始即被纳入,并有一项采用支持性名义群体技术的平行研究(方案另报)。
- 平行系统评价将评估可用测量工具及其心理测量学特性,探索「如何」测量商定的结局域。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Facial palsy affects 45-60% of acute stroke patients, significantly impacting their physical function, communication, and quality of life. Varied outcome measures across studies and clinical practices make it difficult to synthesise evidence and establish treatment effectiveness. This protocol describes in detail the professional stakeholder component of a multistage Core Outcome Set (COS) development programme for post-stroke facial palsy. This component focuses on identifying critically important outcomes (the "what" to measure) between two key stakeholder groups: clinicians and researchers. METHODS: This study follows the Core Outcome Set standards for development (COS-STAD) and protocol (COS-STAP) recommendations. The development process consists of five sequential steps: (1) outcome generation through systematic reviews, consultation with our co-researchers who have lived experience, and the findings from qualitative interviews with stroke participants; (2) recruitment of up to 200 international clinicians and researchers (minimum 30 per group) through clinical networks (including professional associations), social media platforms (X, LinkedIn, Bluesky), and via published research identifying stroke and facial palsy researchers; (3) multiple rounds of Delphi surveys; (4) online consensus meeting (at least five per stakeholder group); and (5) results dissemination. DISCUSSION: This paper reports the detailed protocol for the professional stakeholder component, which will establish consensus among clinicians and researchers on what outcomes are critically important to measure. This protocol addresses a significant gap in stroke rehabilitation research as part of a comprehensive, multi-stage programme to develop a COS for post-stroke facial palsy. Standardising outcome measurement will facilitate more effective synthesis of research findings, reduce research waste, and accelerate intervention development. It describes how people with lived experience have been included from the start and signposts to a parallel study using the supported nominal group technique (detailed protocol reported separately). A parallel systematic review will evaluate available measurement instruments, their psychometric properties to explore "how" to measure the agreed outcome domains. The results of each stage will be disseminated through multiple channels to facilitate widespread research and clinical practice adoption. TRIAL REGISTRATION: Core Outcome Measures in Effectiveness Trials (COMET) registered, December 2024 ( https://www.comet-initiative.org/Studies/Details/3295 ); systematic review registered (PROSPERO), June 2023, CRD42023410768.
引用
- Eroglu HS, Bowen A, Checketts M, et al. Towards the development of a core outcome set for post-stroke facial palsy (COS post-stroke facial palsy): a study protocol for establishing professional consensus on what to measure. Trials. 2026. PMID: 41782010. doi:10.1186/s13063-026-09556-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。